Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Dr. Brahmer Discusses Managing Immunotherapy AEs

September 26th 2013

Julie R. Brahmer, MD, from Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, discusses the management of adverse events (AEs) from treatment with immunotherapies.

Distress Assessment

September 25th 2013

Researchers find that patients are not referred for supportive care services.

Dr. Adjei on Adverse Events From MEK Inhibitors

September 11th 2013

Alex A. Adjei, MD, PhD, Professor and Chair, Department of Medicine, Katherine Anne Gioia Chair in Cancer Medicine, Senior Vice President, Clinical Research, Roswell Park Cancer Institute, discusses eye toxicity from MEK inhibitors.

Ginseng Improves Cancer-Related Fatigue in Phase III Trial

September 3rd 2013

A multisite, randomized, double-blind trial evaluating the fatigue-ameliorating properties of American ginseng in cancer patients and recent survivors has found the herb to be helpful in reducing some aspects of CRF, with the benefit strongest among patients currently in treatment.

On the Genomic Horizon: Analyzing Polymorphisms May Predict Adverse Events

August 26th 2013

Two teams of investigators report that analysis of germline polymorphisms yields valuable clues about which patients may experience adverse events from anticancer therapies.

Study Details Adverse Events in Pivotal Ipilimumab Trial

August 16th 2013

Adverse events associated with ipilimumab for the treatment of metastatic melanoma are better understood after further analysis of clinical trial data that led to the FDA's 2011 approval of the drug.

Palliative Care and Cancer Pain Management

August 13th 2013

Keeping Current in a Complex Cancer Care Environment

August 13th 2013

Oncology Nursing: Partner Perspective Introduction

August 13th 2013

Dr. Lesser on Armodafinil for Radiation-Induced Fatigue

August 1st 2013

Glenn J. Lesser, MD, Professor, Hematology & Oncology, Comprehensive Cancer Center, Wake Forest Baptist Health, discusses armodafinil for brain radiation-induced fatigue.

Research Focuses on Helping Patients to Manage Oral Medications

July 23rd 2013

With more and more cancer therapies being administered as oral agents, oncology nurses have a critical role to play in helping their patients to manage their medications and any side effects of treatment.

On the Frontier of Cancer Care: Holland Helped Pioneer Psychosocial Treatment

July 19th 2013

An Interview With Jimmie C. Holland, MD, on her research and role in the development of a vital area of cancer care.

Most Survivors Not Discussing Psychosocial Needs With Providers

July 16th 2013

Less than one-third of all survivors of adult cancers in the United States had discussions with their healthcare providers about their psychosocial care needs.

Improving Cancer Survivorship: Embedding Tailored, Comprehensive Survivorship Care in the Breast Oncology Clinic

July 10th 2013

Ann Partridge, MD, MPH, from Dana-Farber Cancer Institute and Sandy Truong, a Harvard Medical School student, discuss the needs of cancer survivors and their efforts to optimize survivorship care.

Managing Chemotherapy-Induced Peripheral Neuropathy

July 1st 2013

Chemotherapy-induced peripheral neuropathy is a common side effect in patients with cancer and nurses are essential to helping patients to manage this condition.

Conclusion: Key Take-Away Points and Cardiac Safety

July 1st 2013

Unmet Needs in Renal Cell Carcinoma

July 1st 2013

Immune Checkpoint Inhibition in Renal Cell Carcinoma

July 1st 2013

Novel Agents in Development for Renal Cell Carcinoma

July 1st 2013

INTORSECT Trial: Second-Line Temsirolimus Versus Sorafenib

July 1st 2013